All of the team really enjoy recruiting to Genomicc as it is straightforward with clear goals which are well received by the target populations. Additionally, all aspects of the study have been set up to make the study work pragmatically in the clinical setting, and the team at Genomicc are approachable, supportive and quick to answer queries.
It is exciting to know this study is furthering our knowledge and understanding of the genetic biomarkers of disease severity including COVID-19 and may therefore contribute to improvements in future treatments.
